ResMed Inc (RMD) financials · rev $5.65B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
ResMed Inc (RMD) rev $5.65B.
| Line | FY2026 | FY2025 |
|---|---|---|
| Revenue | $5.65B | $5.15B |
| Cost of Revenue | $2.20B | $2.09B |
| Gross Profit | $3.45B | $3.05B |
| Operating Income | $1.89B | $1.69B |
| Net Income | $1.52B | $1.40B |
| EPS (Diluted) | $10.43 | $9.51 |
| Line | FY2026 | FY2025 |
|---|---|---|
| Total Assets | $8.97B | $8.17B |
| Current Assets | $4.32B | $3.51B |
| Cash & Equivalents | $1.47B | $1.21B |
| Inventory | $945.8M | $927.7M |
| PP&E | $581.8M | $550.8M |
| Total Liabilities | $2.38B | $2.21B |
| Current Liabilities | $1.40B | $1.02B |
| Short-term Debt | $259.9M | $9.90M |
| Long-term Debt | $399.4M | $658.4M |
| Total Debt | $659.4M† | $668.3M† |
| Shareholders' Equity | $6.59B | $5.97B |
| Retained Earnings | $7.26B | $6.08B |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2026 | FY2025 |
|---|---|---|
| Operating Cash Flow | $1.81B | $1.75B |
| CapEx | $156.3M | $89.9M |
| Investing Cash Flow | -$545.2M | -$200.0M |
| Financing Cash Flow | -$1.01B | -$606.3M |
| Dividends Paid | $349.7M | $310.9M |
| Net Change in Cash | $259.8M | $971.1M |
| Free Cash Flow | $1.65B | $1.66B |
FAQ
What is RMD P/E and revenue?
ResMed Inc (RMD) rev $5.65B.
What is RMD revenue?
ResMed Inc last cached revenue is $5.65B (FY2026).
Is RMD profitable?
ResMed Inc last cached net income is $1.52B (FY2026).
What are RMD total assets?
ResMed Inc last cached total assets are $8.97B (FY2026).
What is RMD free cash flow?
ResMed Inc last cached free cash flow is $1.65B (FY2026).
Not investment advice. Cached statements, not a live tape.